Use of dasatinib in chronic myeloid leukemia therapy by O. Yu. Vinogradova, A. G. Turkina, N. D. Choroshko

Get full text

Achievements in diagnostics and treatment of the patients with mieloid leucosis in Russian Federation by G. A. Turkina, O. Yu. Vinogradova, N. D. Khoroshko, A. I. Vorob’yov

Get full text

Results of long-term treatment with thrombopoietin receptor agonists of resistant primary immune thrombocytopenia by O. Yu. Vinogradova, M. M. Pankrashkina, L. A. Mukha, A. L. Neverova, M. V. Chernikov, V. V. Ptushkin

Get full text

Primary and secondary myelofibrosis: ophthalmological manifestations at onset and during therapy by O. Yu. Vinogradova, L. B. Egoryan, D. I. Shikhbabaeva, A. L. Neverova, M. M. Pankrashkina, L. K. Moshetova

Get full text

Characteristics of regional epidemiological indicators of chronic myeloproliferative neoplasms by O. Yu. Vinogradova, A. L. Neverova, M. V. Chernikov, V. P. Kosenkova, M. M. Pankrashkina, D. I. Shikhbabaeva, A. R. Vekua, V. V. Ptushkin

Get full text

Targeted therapy for advanced forms of systemic mastocytosis in real clinical practice by D. I. Shikhbabaeva, O. Yu. Vinogradova, A. L. Neverova, M. M. Pankrashkina, M. V. Chernikov, E. O. Detkina, Yu. N. Kobzev, S. G. Malakho, V. V. Ptushkin

Get full text

Genetic features of indolent and advanced forms of systemic mastocytosis by D. I. Shikhbabaeva, O. Yu. Vinogradova, Yu. N. Kobzev, A. L. Neverova, S. G. Malakho, M. A. Molitvina, M. M. Pankrashkina, M. V. Chernikov, V. V. Ptushkin

Get full text

Possibilities of targeted therapy for myelofibrosis: Moscow experience by O. Yu. Vinogradova, M. M. Pankrashkina, D. I. Shikhbabaeva, M. V. Chernikov, A. L. Neverova, V. L. Ivanova, E. A. Nikitin, E. V. Usikova, V. V. Ptushkin

Get full text

Evolution of therapeutic approaches in patients with chronic myeloid leukemia and T315I mutation by A. G. Turkina, E. G. Lomaia, E. V. Morozova, O. Yu. Vinogradova, T. A. Mitina, Yu. V. Shatokhin, E. G. Ovsyannikova, Yu. Yu. Vlasova, S. M. Kulikov, E. Yu. Chelysheva

Get full text

Clinical and hematological factors predicting the effectiveness of ruxolitinib in primary and secondary myelofibrosis. Results of a prospective single-center study by O. Yu. Vinogradova, M. M. Pankraskina, A. L. Neverova, D. I. Shikhbabaeva, M. A. Murzabekova, M. V. Chernikov, A. V. Popova, V. P. Kosenkova, L. B. Egoryan, V. V. Ptushkin

Get full text

Efficacy of the combination of venetoclax and hypomethylating agents in the treatment of patients with primary, relapsed and/or refractory acute myeloid leukemia by E. V. Usikova, K. D. Kaplanov, V. I. Vorob'ev, T. I. Lobanova, M. A. Ul'yanova, D. G. Kisilichina, Yu. N. Kobzev, D. I. Shikhbabaeva, O. Yu. Vinogradova, V. V. Ptushkin

Get full text

Molecular markers as possible efficacy predictors of targeted therapy for myelofibrosis: single-center study by O. Yu. Vinogradova, D. I. Shikhbabaeva, Yu. N. Kobzev, A. L. Neverova, M. M. Pankraskina, S. G. Malakho, M. V. Chernikov, M. A. Murzabekova, A. G. Popova, L. B. Egoryan, A. V. Krechetova, V. V. Ptushkin

Get full text

Influence of different chromosomal abnormalities in Ph-positive bone marrow cells on the chronic myeloid leukemia course during tyrosine kinase inhibitors therapy by O. Yu. Vinogradova, E. A. Aseeva, A. V. Vorontsova, A. G. Turkina, A. L. Neverova, O. V. Lazareva, E. Yu. Chelysheva, G. A. Gusarova, T. I. Kolosheinova, L. Yu. Kolosova, S. R. Goryacheva, M. V. Vakhrusheva, S. M. Kulikov, I. A. Tishchenko, L. V. Dyachenko, A. I. Udovichenko, G. A. Alimova, E. V. Kleina, L. A. Grebenyuk, M. L. Konnova, S. Yu. Smirnova, N. D. Khoroshko, E. V. Domracheva

Get full text